Shanghai Pharmaceuticals (SHA:601607, HKG:2607) completed the acquisition of a majority stake in Shanghai Hutchison Pharmaceuticals or SHPL, according to a Hong Kong Stock Exchange disclosure on Monday.
The Chinese pharmaceutical company directly and indirectly owns 60% of SHPL. The company directly owns 10% of SHPL, while its subsidiary, Shanghai TCM, will hold 50% of SHPL, the disclosure said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。